Fulcrum Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
12,112
-11,680
-49% -$1.37M 0.16% 168
2026
Q1
$2.81M Buy
23,792
+1,066
+5% +$123K 0.42% 63
2025
Q4
$2.41M Sell
22,726
-673
-3% -$63.2K 0.67% 40
2025
Q3
$1.96M Sell
23,399
-650
-3% -$53.5K 0.54% 50
2025
Q2
$1.9M Buy
+24,049
New +$1.91M 0.54% 49
2022
Q1
Hold
0
70
2021
Q4
Hold
0
27
2021
Q3
Hold
0
27
2021
Q2
Hold
0
32
2021
Q1
Hold
0
21

Other funds holding MRK

Fulcrum Asset Management's MRK Position: Q2 2026 in Review

Fulcrum Asset Management reduced its Merck (MRK) stake by 49% in Q2 2026, selling an estimated $1.37M and leaving 12,112 shares worth $1.57M. The position accounts for 0.16% of the portfolio, ranked #168.

Fulcrum Asset Management first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.81M in Q1 2026. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fulcrum Asset Management held 12,112 shares of Merck worth $1.57M as of Q2 2026.
  • Fulcrum Asset Management sold 11,680 Merck shares in Q2 2026, an estimated $1.37M.
  • Merck made up 0.16% of Fulcrum Asset Management's portfolio in Q2 2026, its #168 holding.
  • Fulcrum Asset Management first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • Fulcrum Asset Management's Merck position peaked at $2.81M in Q1 2026.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.